A commercial outcome, or certainty of one.
The way this board communicates and behaves sows a lot of doubt. The only thing that will create the demand you talk of is when we are registering for a specific use and we are likely to become a standard of care.
Everything else is just more talk from a board who have proven time and again they are totally unreliable.
- Forums
- ASX - By Stock
- PAA
- Ann: Motor Neurone Disease Phase 1/2 Clinical Trial Update
Ann: Motor Neurone Disease Phase 1/2 Clinical Trial Update, page-166
Featured News
Add PAA (ASX) to my watchlist
(20min delay)
|
|||||
Last
20.0¢ |
Change
0.010(5.26%) |
Mkt cap ! $97.28M |
Open | High | Low | Value | Volume |
19.0¢ | 20.5¢ | 19.0¢ | $326.8K | 1.645M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 138704 | 20.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.5¢ | 60000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 136204 | 0.200 |
1 | 10256 | 0.195 |
5 | 300815 | 0.190 |
5 | 139546 | 0.185 |
6 | 189330 | 0.180 |
Price($) | Vol. | No. |
---|---|---|
0.205 | 60000 | 1 |
0.210 | 207000 | 3 |
0.215 | 123372 | 5 |
0.220 | 484543 | 8 |
0.225 | 592637 | 3 |
Last trade - 16.10pm 25/09/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |
The Watchlist
BPH
BPH ENERGY LTD
David Breeze, Managing Director and Executive Chairman
David Breeze
Managing Director and Executive Chairman
SPONSORED BY The Market Online